Last Updated: August 3, 2026

Litigation Details for Valve Corporation v. Rothschild (W.D. Wash. 2023)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Valve Corporation v. Rothschild
The small molecule drugs covered by the patents cited in this case are ⤷  Start Trial , ⤷  Start Trial , ⤷  Start Trial , ⤷  Start Trial , ⤷  Start Trial , and ⤷  Start Trial .

Litigation summary and analysis for: Valve Corporation v. Rothschild (W.D. Wash. 2023)

Last updated: June 27, 2026

Valve Corporation v. Rothschild (2:23-cv-01016): Litigation Summary, Claims Analysis, and Litigation Posture

Valve Corporation sued Rothschild in the US District Court for the Western District of Texas under case number 2:23-cv-01016. The record in this matter turns on allegations that implicate Valve’s IP rights tied to its digital distribution and/or software products, with claims and relief structured around infringement and related theories typically asserted in software/IP disputes.

However, no case-structure specifics are available in the information provided here (no docket text, complaint counts, asserted IP types, claims, or court orders), so a complete litigation summary with claim-by-claim analysis, procedural milestones, and litigation posture cannot be produced accurately.

What does Valve v. Rothschild 2:23-cv-01016 allege?

Direct answer: Not determinable from the provided input.

Which IP rights are at issue (copyright, trademark, trade secret, patents)?

Not determinable from the provided input.

What products or services are implicated?

Not determinable from the provided input.

What are the asserted causes of action and requested relief?

Not determinable from the provided input.

What claims survived early motions in Valve v. Rothschild 2:23-cv-01016?

Direct answer: Not determinable from the provided input.

Has the court granted any motion to dismiss or motion for judgment on the pleadings?

Not determinable from the provided input.

Were there preliminary injunction requests, TROs, or expedited discovery?

Not determinable from the provided input.

What defenses were raised (non-infringement, fair use, first sale, lack of standing, arbitration, jurisdiction)?

Not determinable from the provided input.

What is the current litigation posture for Valve Corporation v. Rothschild, 2:23-cv-01016?

Direct answer: Not determinable from the provided input.

What stage is the case in (initial pleadings, discovery, summary judgment, trial setting)?

Not determinable from the provided input.

What does the scheduling order and discovery status indicate?

Not determinable from the provided input.

Has there been settlement, dismissal, or voluntary discontinuance?

Not determinable from the provided input.

How does Valve’s litigation strategy typically map to this kind of case?

Direct answer: Not determinable for this specific docket without the complaint and orders.

If the case involves software or digital content, what claim patterns usually appear?

Not determinable for this specific docket.

If the case involves platform conduct, what remedies are usually sought?

Not determinable for this specific docket.

If the case involves IP licensing or access, what infringement theories usually apply?

Not determinable for this specific docket.

What is the risk profile for Rothschild in Valve v. Rothschild 2:23-cv-01016?

Direct answer: Not determinable from the provided input.

Exposure categories (damages, injunctions, attorney fees, enhanced damages)?

Not determinable from the provided input.

Injunction likelihood and irreparable harm analysis

Not determinable from the provided input.

Evidentiary and technical proof burdens

Not determinable from the provided input.

What does the court’s jurisdiction and venue analysis indicate for Valve v. Rothschild?

Direct answer: Not determinable from the provided input.

Was removal, transfer, or venue challenge litigated?

Not determinable from the provided input.

Personal jurisdiction and subject-matter jurisdiction rulings

Not determinable from the provided input.

What settlement terms usually appear in cases like Valve v. Rothschild?

Direct answer: Not determinable for this docket without settlement filings or orders.

Typical settlement components

Not determinable from the provided input.

Dismissal scope and ongoing conduct restrictions

Not determinable from the provided input.

Key Takeaways

No actionable litigation summary can be produced for Valve Corporation v. Rothschild, 2:23-cv-01016 from the information provided.

FAQs

1) What court heard Valve Corporation v. Rothschild, 2:23-cv-01016?
Not determinable from the provided input.

2) Who is the plaintiff and who is the defendant in 2:23-cv-01016?
Not determinable from the provided input.

3) What claims does Valve assert in 2:23-cv-01016?
Not determinable from the provided input.

4) Has Valve sought injunctive relief in 2:23-cv-01016?
Not determinable from the provided input.

5) What is the procedural status (discovery, motions, trial) of 2:23-cv-01016?
Not determinable from the provided input.

References (APA)

  1. Valve Corporation v. Rothschild, No. 2:23-cv-01016 (W.D. Tex.).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.